Endo International Stock
€0.010
Your prediction
Endo International Stock
Pros and Cons of Endo International in the next few years
Pros
Cons
Performance of Endo International vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Endo International | - | -9.091% | 900.000% | -88.889% | -75.000% | -99.790% | -99.847% |
| Rockwell Medical Inc. | 1.620% | 1.786% | -4.362% | -26.923% | -20.034% | -85.152% | -96.854% |
| Avid Bioservices Inc | - | 3.279% | 2.439% | -62.500% | 3.279% | -64.000% | 54.601% |
| Gritstone Oncology Inc | -5.040% | 2.001% | -71.460% | -67.715% | -61.598% | -90.636% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Endo International plc (NASDAQ: ENDP), a pharmaceutical company, presents an interesting case when it comes to its financials. At a glance, the company's balance sheet, cash flow, and income statement over the past few years show mixed performance, with some areas of strength and other areas causing concern. This article aims to provide a comprehensive analysis of Endo Intl's financials, highlighting both the positive and negative aspects of the company's standing.
Revenue Growth: Endo Intl's total revenue has shown considerable growth from 2020 to 2022. The revenue increased from $2.90 billion in 2020 to $2.99 billion in 2021 and reached $3.32 billion by 2022. This upward trend indicates that the company is effectively advancing its product offerings and market penetration.
Reduced Research and Development Expenses: The company's research and development (R&D) expenses have gradually decreased over the past few years, dropping from $158.9 million in 2020 to $128 million in 2022. This could signify better efficiency in its R&D efforts, which may potentially lead to higher profitability.
